A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.
Atherosclerosis
; 236(1): 91-100, 2014 Sep.
Article
in En
| MEDLINE
| ID: mdl-25016363
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Aortic Diseases
/
Quinazolines
/
Atherosclerosis
/
Betaine-Homocysteine S-Methyltransferase
/
Hyperlipidemias
Type of study:
Etiology_studies
Language:
En
Journal:
Atherosclerosis
Year:
2014
Document type:
Article
Country of publication:
Irlanda